Table 1.
Animal model | Transplant organ | Drug combination | Median survival |
---|---|---|---|
Rhesus monkey26 | Renal allograft | Abatacept monotherapy | 8 days |
Belatacept monotherapy | 35 days | ||
Belatacept/MMF/steroids | 155 days | ||
Basiliximab induction; belatacept | >100 days | ||
Rhesus monkey51 | Islet allograft | Anti-CD40 monotherapy | 16 days |
Belatacept monotherapy | 59 days | ||
Belatacept/anti-CD40 | 220 days | ||
Rhesus monkey52 | Neonatal islet xenograft | Basiliximab + anti-CD154 induction; belatacept + sirolimus | >140 days |
Rhesus monkey53 | Adult islet xenograft | Basiliximab + anti-CD154 induction; belatacept + sirolimus | 2/5 (20%) engraftment |
Abbreviation: MMF, mycophenolate mofetil.